(Q51357183)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22568403%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

VEGF is indirectly associated with NO production and acutely increases in response to hyperglycaemia(1) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22568403%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22568403%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Martin Feelisch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22568403%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Blossom C. Stephan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22568403%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Virginia Tomatis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22568403%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Les J C Bluck

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22568403%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

8 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22568403%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Investigation

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22568403%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22568403%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22568403%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

967-973

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22568403%20AND%20SRC:MED&resulttype=core&format=json

Current insights on the biology and clinical aspects of VEGF regulation

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Evidence for a relationship between VEGF and BMI independent of insulin sensitivity by glucose clamp procedure in a homogenous group healthy young men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Measurement of in vivo nitric oxide synthesis in humans using stable isotopic methods: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

A catalogue of reporting guidelines for health research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

A novel derivative for the assessment of urinary and salivary nitrate using gas chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Analysis of covariance using the rank transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Angiogenic factors are elevated in overweight and obese individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Effects of diabetes and obesity on vascular reactivity, inflammatory cytokines, and growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

Vascular endothelial growth factor B controls endothelial fatty acid uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X

The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02684.X